|Articles|October 1, 2019

Advances in Gene Therapy Analytics

Newsletter

Stay at the forefront of biopharmaceutical innovation. Subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe

Related Content

Nuno Fontes, man in black suit jacket and white button down standing in front of blue and white background for interview

Expanding CDMO Capabilities in Drug Manufacturing

ByNuno Fontes, SVP, Head of Global CMC,WuXi Biologics

May 14th 2026

Sponsored

How Biologic Developers are Using Optimized Platforms and Operations to Reach First-in-Human Trials

ByEmily Schirmer, Catalent,Jeanne Linke Northrop, BioPharm International

May 13th 2026

Sponsored

Choosing the Right CDMO for Long-Term Stability

ByDr. Patrick Meyer, Global Head of Business Development,Rentschler Biopharma

Published: May 4th 2026 | Updated: May 4th 2026

Sponsored

Reducing Timelines and Eliminating the White Space in Complex Biologic & Bioconjugate Development

ByCampbell Bunce,Abzena

Published: April 23rd 2026 | Updated: January 14th 2026

Sponsored

Tech Transfer Powered by Dual Site Precision

ByHenning Gerschewski, VP Manufacturing Science & Technology, Rentschler BioPharma,Patrick Cushing, Vice President of Operations, Rentschler Biopharma,Rentschler Biopharma

April 7th 2026

Sponsored